Cargando…

The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada

PURPOSE: Fluoro-2-deoxyglucose positron-emission tomography (FDG-PET/CT) is now considered a standard investigation for the staging of new cases of stage III NSCLC. However, there is not published level 3 evidence demonstrating the impact of FDG-PET/CT on appropriate therapy in this setting. Using r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beers, Craig A., Pond, Gregory R., Wright, James R., Tsakiridis, Theodoros, Okawara, Gordon S., Swaminath, Anand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482027/ https://www.ncbi.nlm.nih.gov/pubmed/37681028 http://dx.doi.org/10.3389/fonc.2023.1210945

Ejemplares similares

Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer
por: Gouran-Savadkoohi, Mohammad, et al.
Publicado: (2023)

Impact of EBUS-TBNA in addition to [(18)F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
por: Guberina, Maja, et al.
Publicado: (2021)

Metabolic patterns on [(18)F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment
por: Holzgreve, Adrien, et al.
Publicado: (2023)

Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
por: Watanabe, Shiro, et al.
Publicado: (2019)

Lung Cancer Inequalities in Stage of Diagnosis in Ontario, Canada
por: Lofters, Aisha K., et al.
Publicado: (2021)

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and (18)F-FDG PET/CT for radiotherapy target volume definition
por: Guberina, Maja, et al.
Publicado: (2021)

Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial
por: Konert, T., et al.
Publicado: (2019)

Impact of staging with (18)F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors
por: Eschmann, S. M., et al.
Publicado: (2006)

Impact of (18)F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC
por: Al-Ibraheem, Akram, et al.
Publicado: (2021)

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC
por: Crandall, John P., et al.
Publicado: (2017)

Immunotherapy for Stage III NSCLC: Durvalumab and Beyond
por: Fitzpatrick, Orla, et al.
Publicado: (2021)

FDG PET/CT in the Staging of Lung Cancer
por: Farsad, Mohsen
Publicado: (2020)

The current treatment landscape in the UK for stage III NSCLC
por: Evison, Matthew
Publicado: (2020)

Hematogenous muscular metastasis of NSCLC in FDG-PET/CT
por: Satoh, Hiroaki, et al.
Publicado: (2015)

Implications of False Negative and False Positive Diagnosis in Lymph Node Staging of NSCLC by Means of (18)F-FDG PET/CT
por: Li, Shaolei, et al.
Publicado: (2013)

Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [(18)F]FDG PET/CT: A Comparison between Two PET/CT Scanners
por: Dondi, Francesco, et al.
Publicado: (2022)

Prognostic Impact of (18)FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer
por: Groheux, David, et al.
Publicado: (2012)

The value of head imaging after PET-CT staging in NSCLC
por: Kamil, A, et al.
Publicado: (2015)

Differences in the breast cancer diagnostic process across stage groups in Ontario, Canada
por: Groome, Patti, et al.
Publicado: (2017)

Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease
por: Sathiyapalan, Arani, et al.
Publicado: (2023)

FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma
por: Roberge, David, et al.
Publicado: (2012)

Staging recurrent ovarian cancer with (18)FDG PET/CT
por: DRAGOSAVAC, SANJA, et al.
Publicado: (2013)

(18)F-FDG PET-CT for Staging of Conjunctival Melanoma
por: Damian, Andres, et al.
Publicado: (2013)

Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma
por: Calabrese, Cecilia, et al.
Publicado: (2016)

Breast cancer: initial workup and staging with FDG PET/CT
por: Groheux, David, et al.
Publicado: (2021)

Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation Therapy
por: MacManus, Michael P., et al.
Publicado: (2020)

Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival
por: Kudura, Ken, et al.
Publicado: (2023)

Evaluate the outcome of pneumonectomy for stage III a-N2 NSCLC
por: Park, Sungjoon, et al.
Publicado: (2015)

Neoadjuvant Immuno-Chemotherapy: A New Perspective for Stage III NSCLC?
por: Yao, Yuanshan, et al.
Publicado: (2022)

Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment
por: Agbarya, Abed, et al.
Publicado: (2022)

Prone versus Supine FDG PET/CT in the Staging of Breast Cancer
por: Nassar, Lara, et al.
Publicado: (2023)

FDG-PET/CT for lymph node staging prior to radical cystectomy
por: Pihl, Vilhelm, et al.
Publicado: (2023)

Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC
por: Shaverdian, Narek, et al.
Publicado: (2021)

The Impact of (18)F-FDG PET CT Prior to Chemoradiotherapy for Stage III/IV Head and Neck Squamous Cell Carcinoma
por: Prestwich, Robin J. D., et al.
Publicado: (2012)

S‐100B as an extra selection tool for FDG PET/CT scanning in follow‐up of AJCC stage III melanoma patients
por: Deckers, Eric A., et al.
Publicado: (2019)

Value of pre-treatment (18)F-FDG PET/CT radiomics in predicting the prognosis of stage III-IV colorectal cancer
por: Wang, Na, et al.
Publicado: (2023)

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
por: Mistry, Vijay, et al.
Publicado: (2023)

Tracheo-parenchymal fistula following concurrent chemo-radiation for stage III NSCLC
por: Alzghoul, Bashar, et al.
Publicado: (2016)

Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy
por: Iseli, Thomas, et al.
Publicado: (2020)

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC
por: Kinehara, Yuhei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cektoecrmpdcp9fh9kv9gd25a1